RTW INVESTMENTS, LP
CIK 1493215 · last filed 2025-11-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RNA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
7TH FLOOR
NEW YORK, NY 10014
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALLURION TECHNOLOGIES, INC. (ALUR.WS) Delisted | Director | 26,551 | $0.01 | $316 | $0 | 1 | 2025-11-13 |
| ROCKET PHARMACEUTICALS, INC. (RCKTW) Delisted | Director | 18,236,124 | $0.00 | $36.5K | $0 | 3 | 2025-09-23 |
| OBIO | 10%+ Owner | 8,306,063 | $5.55 | $46.10M | $551.4K | 2 | 2025-05-01 |
| MIST | 10%+ Owner | 3,256,102 | $0.64 | $2.10M | $45.54M | 7 | 2023-03-24 |
| RCKT | Director | 16,185,119 | $2.28 | $36.90M | $41.62M | 5 | 2022-12-22 |
| DermTech, Inc. (DMTK) Delisted | 10%+ Owner | 3,018,666 | $0.09 | $283.8K | $13.32M | 4 | 2022-11-08 |
| Landos Biopharma, Inc. (LABP) Delisted | 10%+ Owner | 397,572 | $22.93 | $9.12M | -$414.0K | 1 | 2022-09-27 |
| Renovacor, Inc. (RCOR.WS) Delisted | 10%+ Owner | 2,805,640 | $0.07 | $199.2K | $8.16M | 4 | 2022-01-14 |
| RNA | 10%+ Owner | 4,795,000 | $8.05 | $38.60M | $63.00M | 2 | 2021-08-06 |
| TARS | 10%+ Owner | 2,013,601 | $70.03 | $141.01M | -$26.98M | 1 | 2021-05-07 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | 10%+ Owner | 3,264,031 | $199.92 | $652.55M | $30.40M | 1 | 2021-03-16 |
| LeonaBio, Inc. (ATHA) Delisted | 10%+ Owner | 191,891 | $6.92 | $1.33M | $25.50M | 1 | 2020-09-22 |
| TELA | 10%+ Owner | 1,139,358 | $0.98 | $1.12M | -$815.2K | 1 | 2019-12-18 |
| STOK | 10%+ Owner | 3,544,248 | $25.46 | $90.24M | $24.38M | 4 | 2019-11-12 |
Recent Filings · Page 2 of 4
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-27 | Landos Biopharma, Inc. (LABP) Delisted | Sell (S) | −600,000 | -$414.0K | EDGAR |
| 2022-01-14 | Renovacor, Inc. (RCOR.WS) Delisted | Buy (P) | +305,918 | $2.45M | EDGAR |
| 2022-01-06 | Renovacor, Inc. (RCOR.WS) Delisted | Buy (P) | +454,484 | $3.64M | EDGAR |
| 2021-11-17 | Renovacor, Inc. (RCOR.WS) Delisted | Buy (P) | +203,673 | $1.83M | EDGAR |
| 2021-11-12 | Renovacor, Inc. (RCOR.WS) Delisted | Buy (P) | +29,697 | $245.7K | EDGAR |
| 2021-08-06 | RNA | Mixed | +1,600,000 | $28.80M | EDGAR |
| 2021-05-07 | TARS | Sell (S) | −900,000 | -$26.98M | EDGAR |
| 2021-03-29 | RCKT | Other (J) | −4,034,775 | $0 | EDGAR |
| 2021-03-16 | Prometheus Biosciences, Inc. (RXDX) Delisted | Mixed | +6,528,062 | $30.40M | EDGAR |
| 2021-01-11 | DermTech, Inc. (DMTK) Delisted | Buy (P) | +400,000 | $11.80M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.